Fundacion Respirar

Ciudad Autonoma de Buenos Aires, Buenos Aires C1426ABP

1 studies enrolling now · 5 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Atopic Dermatitis, Limited Stage Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC)

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) — Completed
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) — Running, not enrolling
• A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC — Running, not enrolling